VIDEO: Microbiome wipe aims to simplify, encourage at-home gut health testing

In this Healio video exclusive, Nathan Price, PhD, chief scientific officer at Thorne HealthTech, discusses the development of a new microbiome wipe that could change the landscape of at-home gut health testing.According to Price, an existing barrier for at-home testing has been the stool collection process, which involves transferring a fecal sample into a vile….

‘They are counting on us’: AMA adopts policies to help limit insurance loss

Since the COVID-19 pandemic began, the world has hoped for an end to the public health emergency — but that distinction could also mean millions losing their insurance coverage.Patients enrolled in Medicaid and the Children’s Health Insurance Program (CHIP) have been protected by a requirement in which states must continue to provide coverage to these…

FDA approves Skyrizi for moderately to severely active Crohn’s disease

The FDA has approved AbbVie’s Skyrizi for the treatment of adults with moderately to severely active Crohn’s disease, according to a company press release.Previously approved in the United States for the treatment of adult patients with moderately to severely active plaque psoriasis and psoriatic arthritis, Skyrizi (risankizumab-rzaa, AbbVie) is the first interleukin-23 inhibitor to enter…